A test result arrives and it says something unexpected. The immediate reaction is almost always to
treat it as a fact about your body. Often it is not — or not yet. It is a probability
statement, and how likely it is to be right depends heavily on something the result itself does not
tell you: how common the condition is among people like you.
This is a companion to our guide to what preventive screening is and what it can miss. It explains why tests are wrong more often than most people expect, what overdiagnosis
means and why it is the hardest harm to see, and how to read a result without either panicking or
dismissing it.
No test is a yes-or-no machine
Every test has two ways of being wrong.
- A false positive says something is there when it is not.
- A false negative says nothing is there when something is.
These are not defects in a badly made test. They are properties of every test, because tests
measure a proxy — a chemical level, a density on an image, an electrical pattern — and
the ranges for people with and without a condition always overlap somewhat.
Two terms describe how a test handles that overlap:
- Sensitivity — how good it is at catching people who do have the
condition. High sensitivity means few false negatives. - Specificity — how good it is at clearing people who do not. High
specificity means few false positives.
The two trade off against each other. A test tuned to miss almost nobody will flag more healthy
people; one tuned to avoid false alarms will miss more real cases. Where a test is set on that dial
is a deliberate design choice, not an accident.
Why a positive result on a rare condition is usually wrong
This is the part that is genuinely counter-intuitive, and it is the single most useful idea in
this article.
Imagine a test with 99% specificity — it wrongly flags only 1 in 100 healthy people. That
sounds excellent. Now apply it to 10,000 people for a condition that affects 1 in 1,000.
- About 10 people actually have the condition. A good test finds most of them — say 9.
- About 9,990 do not. One per cent of them are wrongly flagged — about 100 people.
So roughly 109 people get a positive result, and only 9 of them have the condition. More
than 90% of the positives are false — from a test that is 99% specific.
Nothing is wrong with the test. The arithmetic is driven by how rare the condition is. This is
why testing a broad, low-risk population for an uncommon condition produces a flood of false alarms,
and why the same test used in people with symptoms or known risk factors performs far better: in
that group, the condition is more common to begin with, so a positive result carries more weight.
It is also the mathematical reason screening guidelines are bounded by age and risk rather than offered to everyone.
Overdiagnosis: the harm that does not look like one
Overdiagnosis is different from a false positive, and the distinction matters.
- A false positive finds something that is not there.
- Overdiagnosis finds something that is there, correctly, but that would
never have caused symptoms or shortened your life.
The finding is real. The biopsy confirms it. Nobody made a mistake. And yet treating it delivers
no benefit, while carrying every ordinary risk of treatment — surgery, medication, side
effects, cost, and the permanent status of being a patient.
Overdiagnosis is hard to see because it is invisible at the individual level. A person who is
overdiagnosed and treated appears to be a success story: something was found, it was treated, they
are fine. Nobody can know they would have been fine anyway. The phenomenon is only visible in
population data — when a screening programme finds far more cases than ever went on to cause
harm before screening existed.
Because you cannot tell in advance which findings would have stayed harmless, overdiagnosis is
genuinely difficult to avoid rather than simply careless. It is a real cost of screening that an
honest account has to include.
Incidental findings
Broad imaging frequently finds something unrelated to what was being looked for — a nodule,
a cyst, an anatomical variation. A minority matter. Most do not. But separating the two usually
means more scans, sometimes a biopsy, and a period of monitoring.
The clinical term for a small, probably harmless finding of uncertain significance is sometimes
half-jokingly called an incidentaloma. The joke reflects a real problem: once something is
on a record, it is difficult to leave alone, even when leaving it alone is the right answer.
Reading your own results without spiralling
A positive screening result is not a diagnosis. It is a reason to do a
diagnostic test. The screening result opens the question; something else closes it.
A normal result is reassurance, not a guarantee. False negatives exist. If a
symptom appears later, a clear test from before does not answer it — and it is not a reason
to wait.
A number outside the reference range is not automatically abnormal. Reference
ranges are usually set so that a percentage of healthy people fall outside them by definition. On a
panel of twenty measurements, at least one falling outside its range is the expected outcome, not a
surprise.
Trend usually beats a single reading. One blood pressure measurement in a
clinic is weak evidence; a series taken over time in ordinary conditions is much stronger. This is
precisely why national guidance recommends confirming raised blood pressure outside the clinical
setting before starting treatment.
Questions worth asking about any result
- Is this a screening test or a diagnostic test?
- Given my age and risk, how likely is it that this positive result is real?
- What is the next step to confirm or rule it out, and how long will it take?
- What happens if we do nothing and repeat the test later?
- If this is confirmed, does treating it change my outcome — or only my paperwork?
- Is this finding what we were looking for, or something we found along the way?
That fifth question is the one most worth asking, and the one least often asked.
What to take from this
- Every test has false positives and false negatives; this is design, not failure.
- For an uncommon condition in a low-risk population, most positive results are false —
even from a very specific test. - Overdiagnosis means correctly finding something that would never have harmed you, and it is
invisible in any individual case. - A positive screening result opens a question; a diagnostic test closes it.
- A normal result does not override a symptom that appears afterwards.
- Trends are more informative than single readings.
- Before buying a screening bundle, work through the ten questions.
Sources
- U.S. Preventive Services Task Force — A and B Recommendations
- USPSTF Recommendations for Physical Examination Procedures for Average Risk Asymptomatic Adults (NCBI Bookshelf)
MediVara publishes health journalism. This article is not medical advice and is not reviewed
by a licensed clinician. Interpreting your own test results is something to do with a qualified
healthcare professional who knows your history.
Frequently asked questions
Does a positive screening result mean I have the disease?
No. A positive screening result means your risk is higher than it was before the test, and that a diagnostic test is warranted. For an uncommon condition in a low-risk population, the majority of positive screening results turn out to be false. The screening result opens the question; a diagnostic test closes it.
Why are false positives so common?
Because of how rare the condition is, not because the test is bad. Take a test that wrongly flags only 1 percent of healthy people, applied to 10,000 people for a condition affecting 1 in 1,000. Around 10 people have it and about 9 are found. Of the 9,990 who do not, 1 percent are wrongly flagged, which is about 100 people. So roughly 109 positives appear and only 9 are real. Over 90 percent are false, from a test that is 99 percent specific.
What is overdiagnosis?
Overdiagnosis is correctly finding a real abnormality that would never have caused symptoms or shortened your life. It differs from a false positive, where nothing is there at all. The finding is genuine, but treating it provides no benefit while carrying the usual risks of treatment. It is invisible in any individual case, because nobody can know that a treated person would have been fine anyway.
What is the difference between sensitivity and specificity?
Sensitivity is how well a test catches people who do have the condition, so high sensitivity means few false negatives. Specificity is how well it clears people who do not, so high specificity means few false positives. The two trade off against each other, and where a test sits on that dial is a deliberate design choice.
Should I worry about one abnormal number on a blood panel?
Not necessarily. Reference ranges are typically set so that a percentage of healthy people fall outside them by definition. On a panel of twenty measurements, at least one result outside its range is the expected outcome rather than a surprise. A trend across several readings is far more informative than a single value.
Leave a Reply